SpectraCure AB (publ) (STO:SPEC)

Market Cap	30.24M -30.8%
Revenue (ttm)	-101.00K
Net Income	-55.90M
EPS	-0.13
Shares Out	570.60M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,072,149
Open	0.0530
Previous Close	0.0530
Day's Range	0.0462 - 0.0595
52-Week Range	0.0438 - 0.3795
Beta	0.47
Analysts	n/a
Price Target	27.50 (+59,423.81%)
Earnings Date	Aug 14, 2026

About SpectraCure AB

SpectraCure AB (publ) engages in the development of cancer treatment system in Sweden. It develops Q-PRO, a laser unit; IDOSE software platform, which calculates the optimal laser light dose and placement of the optical fibers; and disposable items comprising needles, optical fibers, and light-sensitive medication. The company was incorporated in 2003 and is based in Lund, Sweden.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2003
• Employees: 13
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: SPEC

Financial Performance

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jun 15, 2026

Data Sources Report a data error